trial · primary record
Albuterol Sulfate, 2.5 Mg/3 mL (0.083%) Inhalation Solution
Chronic Obstructive Pulmonary Disease
| Phase | Phase 1 |
|---|---|
| Status | ACTIVE |
| Sponsor | Unknown |
| Enrolment | 6 |
| Primary completion | 2026-12-31 |
| Primary endpoint | Ventilation Defect Percent |
| Registry ID | NCT06271408 |
Provenance
- Source: ClinicalTrials.gov
- Fetched at: 2026-10-28T03:27:47.472Z
- Licence class: attribution-required
- Verdict: primary-source
- Entity id: NCT06271408
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.